Published in
Springer (part of Springer Nature), Cancer Chemotherapy and Pharmacology, 6(71), p. 1531-1540
DOI: 10.1007/s00280-013-2152-7
Links
- ORCID
- ORCID
- Springer (part of Springer Nature)
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy
Journal article published in 2013 by
Elisabeth G. Vichaya 
,
Xin Shelley Wang,
Jessica A. Boyette-Davis,
Tito R. Mendoza,
Zijing He,
Sheeba K. Thomas,
Nina Shah,
Loretta A. Williams,
Charles S. Cleeland,
Patrick M. Dougherty
,
Xin Shelley Wang,
Jessica A. Boyette-Davis,
Tito R. Mendoza,
Zijing He,
Sheeba K. Thomas,
Nina Shah,
Loretta A. Williams,
Charles S. Cleeland,
Patrick M. Dougherty
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 